FDA Grants Saranas DeNovo Designation for the Early Bird® Bleed Monitoring System

Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird® Bleed Monitoring System.